These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2423365)

  • 41. Effect of duodenal trypsin on pancreatic secretion in men.
    Czajkowski A; Długosz J
    Acta Physiol Pol; 1989; 40(5-6):486-95. PubMed ID: 2484946
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [INTRAPANCREATIC ACTIVATION OF PROTEOLYTIC ENZYMES AND THE EFFECT OF TRASYLOL IN EXPERIMENTAL PANCREATITIS IN RATS].
    CREUTZFELDT W; SOELING HD; KETTERER H
    Klin Wochenschr; 1963 Oct; 41():1002-7. PubMed ID: 14094378
    [No Abstract]   [Full Text] [Related]  

  • 43. [The effect of synthetic trypsin inhibitors on the kinin-liberating effect of trypsin and pancreatic kallikrein].
    Markwardt F; Walsmann P; Drawert J
    Acta Biol Med Ger; 1970; 24(3):401-4. PubMed ID: 5510483
    [No Abstract]   [Full Text] [Related]  

  • 44. [Effect of kontrikal on the activity of proteolytic enzymes and their inhibitors in blood, state of the bronchoalveolar secretion and the nature of the lung damage in dysenteric intoxication].
    Protsenko VA; Opryshko VV; Nesterov EN; Bogadel'nikov IV; Kharchenko VZ
    Farmakol Toksikol; 1981; 44(5):589-93. PubMed ID: 6171453
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vectorial secretion of a kallikrein-like enzyme by cultured renal cells. I. General properties.
    Jovov B; Wills NK; Donaldson PJ; Lewis SA
    Am J Physiol; 1990 Dec; 259(6 Pt 1):C869-82. PubMed ID: 1701967
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Kallikrein activity and non-specific esterolytic activity of proteases in experimental hemorrhagic shock of varying duration and depth].
    Kühne H; Scheuch DW
    Z Med Lab Diagn; 1979 Feb; 20(1):20-3. PubMed ID: 452638
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effect of proteolysis enzymes and their inhibitors on oxygen uptake by rat brain tissue and its antitryptic activity].
    Veselov VF; Protsenko VA
    Ukr Biokhim Zh (1978); 1981; 53(4):106-9. PubMed ID: 6912731
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Kallikrein and protease activity in the plasma of shock syndrome patients].
    Kühne H; Mecke B; Scheuch DW
    Khirurgiia (Sofiia); 1980; 33(5):385-9. PubMed ID: 7003215
    [No Abstract]   [Full Text] [Related]  

  • 49. [Change in the proteolytic activity of the blood serum from the lower extremities on the experimental intra-arterial administration of the enzymes].
    Khachatrian GS; Baziian RA
    Zh Eksp Klin Med; 1979; 19(4):15-9. PubMed ID: 574344
    [No Abstract]   [Full Text] [Related]  

  • 50. Rapid separation and measurement of rat urinary kallikrein by high-performance liquid chromatography with a continuous flow enzyme detector.
    Funae Y; Akiyama H; Imaoka S; Takaoka M; Morimoto S
    J Chromatogr; 1983 Jul; 264(2):249-57. PubMed ID: 6193135
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Behavior of plasma kallikrein and protease activities in hemorrhagic shock of the dog].
    Kühne H; Scheuch DW
    Z Med Lab Diagn; 1977 Jun; 18(3):169-76. PubMed ID: 899160
    [No Abstract]   [Full Text] [Related]  

  • 52. [On the esterase effects of kallikrein and trypsin and their inhibition by kallikrein-and trypsin inhibitors].
    WERLE E; KAUFMANN-BOETSCH B
    Hoppe Seylers Z Physiol Chem; 1960; 319():52-63. PubMed ID: 13784428
    [No Abstract]   [Full Text] [Related]  

  • 53. [The effect of waxes from essential-oil plants on the dehydrogenase activity of the blood neutrophils in mucosal trauma of the mouth].
    Sysoev NP
    Stomatologiia (Mosk); 1991; 70(1):12-3. PubMed ID: 2057940
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of pancreatic kallikrein and trypsin inhibitors on the course of postischemic toxemia].
    Kharchenko VZ; Protsenko VA
    Farmakol Toksikol; 1977; 40(5):609-13. PubMed ID: 303576
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effects of urinastatin on an energy metabolism disorder during shock].
    Sato M; Ishikawa H; Niho T; Mizota M
    Nihon Yakurigaku Zasshi; 1986 Sep; 88(3):195-203. PubMed ID: 2431982
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effect of the protease inhibitor contrical on liver and serum proteolytic enzyme activity in experimental cholestasis].
    Synovets AS; Pustovoĭt PI; Levitskiĭ AP
    Klin Khir (1962); 1983 Sep; (9):66-7. PubMed ID: 6195387
    [No Abstract]   [Full Text] [Related]  

  • 57. The effects of human kallikrein and aprotinin on nonmalignant and malignant cell growth.
    Korbelik M; Skrk J; Poljak-Blazi M; Suhar A; Boranić M
    Adv Exp Med Biol; 1989; 247B():675-80. PubMed ID: 2481955
    [No Abstract]   [Full Text] [Related]  

  • 58. [The role of erythrocytes in the regulation of the activity of non-specific resistance factors during toxic liver injury].
    Stepanov IuB; Chalyĭ GA; Prokopenko LG
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Dec; (12):78-83. PubMed ID: 2435090
    [No Abstract]   [Full Text] [Related]  

  • 59. [Biogenesis of erythropoietin. II. Extrarenal enzymatic mechanisms].
    Baciu I; Dorofteiu M; Olteanu A; Pavel T; Daniello R
    Fiziol Norm Patol; 1973; 19(2):127-36. PubMed ID: 4540784
    [No Abstract]   [Full Text] [Related]  

  • 60. [Blood preservation with trasylol, a method for preventing proteolytic enzyme activation].
    MARGGRAF W
    Bibl Haematol; 1963; 16():259-64. PubMed ID: 13933008
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.